Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.

Drug Deliv · 2018 · PMC6058670 · PMID 29275639

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

(3) and (4) , X 1 (ratio of drug to polymer) and X 2 (ratio of organic to aqueous phase) had highly significant effects on both the DL and EE of RM–MS.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.